This area is reserved for registered users. Please register or login.

Binosto – A once weekly, buffered alendronate solution for the treatment of osteoporosis

Clonmel Healthcare Ltd is pleased to announce that Binosto (alendronic acid 70mg, once weekly effervescent tablets) is now available in Ireland. It is indicated for the treatment of postmenopausal osteoporosis, and reduces the risk of vertebral and hip fractures.1 Binosto is the first and only buffered alendronate oral solution designed to help minimise gastric tolerability issues.   Osteoporotic fractures impose a huge social and economic cost in Ireland, approximately €402 million per annum is spent to treat all falls and fractures which occur in senior citizens with osteoporosis in Ireland. In addition to healthcare costs, vertebral fractures can cause back…